Adam Kole
Radiation Oncology · Birmingham, ALNPI 1679918940
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,000 of the $10,553 with a category attached, or 94.8%. Medtronic accounts for 96.0% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $10,182, more than ten times the $14 reported in 2021. Among radiation oncology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 21 payments — averaging $502.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$10K
- Siemens Medical Solutions USA, Inc.$201
- Merck$53
- Lilly USA, LLC$30
- Exelixis Inc.$26
- AVEO Pharmaceuticals, Inc.$25
- plus $87 from 4 others
What the payments were for
- Speaking & faculty fees$10,00095%
- Food & beverage$5535%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 9 | $10,132 |
| Siemens Medical Solutions USA, Inc. | 2 | $201 |
| Merck | 2 | $53 |
| Lilly USA, LLC | 2 | $30 |
| Exelixis Inc. | 1 | $26 |
| AVEO Pharmaceuticals, Inc. | 1 | $25 |
| Novartis | 1 | $24 |
| Incyte Corporation | 1 | $23 |
| Deciphera Pharmaceuticals Inc. | 1 | $21 |
| Progenics Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ILLUMISITE$2,609
How this compares
$10,553 in reported general payments places this provider in the 95th percentile of 87 radiation oncology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $190 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Birmingham
- Drexell BoggsBirmingham$35K
- Christopher WilleyBirmingham$13K
- Andrew McDonaldBirmingham$8K
- William EnnisBirmingham$6K
- John StahlBirmingham$3K
- Omer BurnettBirmingham$2K
- Samuel MarcromBirmingham$2K
- Rojymon JacobBirmingham$1K
- Mehran YusufBirmingham$1K
- Ruby MeredithBirmingham$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.